Phase 2 Osteoporosis Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
HealthyOsteoporosis RiskOsteopenia
Odense University Hospital148 enrolled2 locationsNCT07191353
Recruiting
Phase 2
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
OsteoporosisCritical Illness
Australian and New Zealand Intensive Care Research Centre450 enrolled22 locationsNCT04608630
Recruiting
Phase 2
COMPASS - COpenhagen MenoPAuSe Study
Menopausal OsteoporosisBone Markers
Martin Blomberg Jensen192 enrolled1 locationNCT07254429
Recruiting
Phase 2
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Osteoporosis
Duke University45 enrolled1 locationNCT06041789
Recruiting
Phase 2
Identifying Individuals At Risk of Glucocorticoid-Induced Impairment of Bone Disease
Osteoporosis Secondary
Odense University Hospital36 enrolled2 locationsNCT06421597
Recruiting
Phase 2
Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
Osteoporosis
Shinshu University90 enrolled1 locationNCT03755193
Recruiting
Phase 2
Effect of Zoledronic Acid or Denosumab on Bone Loss in Critically Ill Adults – A Randomised Controlled Trial
Osteoporosis
Monash University450 enrolled22 locationsACTRN12621000085875
Recruiting
Phase 2
Effect of denosumab and zoledronic acid on bone turnover markers in critically ill women
Osteoporosis
University Hospital Geelong30 enrolled3 locationsACTRN12617000545369
Completed
Phase 2
A Phase 2a Open Label Study to Evaluate the Pharmacokinetics and Safety of Parathyroid Hormone hPTH(1-34) Administered via Transdermal Delivery and Subcutaneous Injection [Forteo Registered Trademark (teriparatide)] in Healthy Postmenopausal Women
Osteoporosis
Corium International, Inc39 enrolled1 locationACTRN12615000195550
Completed
Phase 2
The effect of low dose fluoride on bone
Osteoporosis
Associate Professor Andrew Grey180 enrolled1 locationACTRN12607000128493